Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

24. August 2020 08:00 ET | Quelle: Biocept, Inc.

Biocept Names Michael Dugan, M.D. Chief Medical Officer and Medical Director

SAN DIEGO, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information...
20. August 2020 08:30 ET | Quelle: Biocept, Inc.

Biocept to Present at the Proactive One2One Virtual Investor Forum on August 25

SAN DIEGO, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information...
19. August 2020 08:00 ET | Quelle: Biocept, Inc.

Biocept Expands Agreement with MultiPlan to Include COVID-19 Testing

SAN DIEGO, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable...
12. Mai 2015 16:05 ET | Quelle: Biocept, Inc.

Biocept Reports First Quarter 2015 Financial Results

Announces Increased Revenues and Strong Year-over-Year Growth in Test Volume Conference call begins at 4:30 p.m. Eastern time today SAN DIEGO, May 12, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc....
04. Mai 2015 16:15 ET | Quelle: Biocept, Inc.

Biocept, Inc. Schedules Webcast and Conference Call for First Quarter 2015 Financial Results

SAN DIEGO, May 4, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and Circulating...
04. Mai 2015 08:30 ET | Quelle: Biocept, Inc.

Biocept Expands Oncology Diagnostic Portfolio With Launch of c-MET Biomarker

SAN DIEGO, May 4, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and circulating...
24. März 2015 08:30 ET | Quelle: Biocept, Inc.

Biocept Enters Clinical Collaboration With University of California, San Diego Moores Cancer Center

SAN DIEGO, March 24, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and circulating...
10. März 2015 08:30 ET | Quelle: Biocept, Inc.

Biocept Expands Non-Small Cell Lung Cancer Diagnostic Capabilities for EGFR Mutations

SAN DIEGO, March 10, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and circulating...
09. März 2015 16:05 ET | Quelle: Biocept, Inc.

Biocept Reports Fourth Quarter 2014 Financial Results

SAN DIEGO, March 9, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and circulating...
05. März 2015 08:30 ET | Quelle: Biocept, Inc.

Next Generation Sequencing Veteran Joins Biocept

SAN DIEGO, March 5, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA)...

Nächste Seite